172 related articles for article (PubMed ID: 21753228)
1. Wnt and Kras signaling-dark siblings in lung cancer.
Pacheco-Pinedo EC; Morrisey EE
Oncotarget; 2011 Jul; 2(7):569-74. PubMed ID: 21753228
[TBL] [Abstract][Full Text] [Related]
2. Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium.
Pacheco-Pinedo EC; Durham AC; Stewart KM; Goss AM; Lu MM; Demayo FJ; Morrisey EE
J Clin Invest; 2011 May; 121(5):1935-45. PubMed ID: 21490395
[TBL] [Abstract][Full Text] [Related]
3. Reconstructing targetable pathways in lung cancer by integrating diverse omics data.
Balbin OA; Prensner JR; Sahu A; Yocum A; Shankar S; Malik R; Fermin D; Dhanasekaran SM; Chandler B; Thomas D; Beer DG; Cao X; Nesvizhskii AI; Chinnaiyan AM
Nat Commun; 2013; 4():2617. PubMed ID: 24135919
[TBL] [Abstract][Full Text] [Related]
4. A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors.
Loboda A; Nebozhyn M; Klinghoffer R; Frazier J; Chastain M; Arthur W; Roberts B; Zhang T; Chenard M; Haines B; Andersen J; Nagashima K; Paweletz C; Lynch B; Feldman I; Dai H; Huang P; Watters J
BMC Med Genomics; 2010 Jun; 3():26. PubMed ID: 20591134
[TBL] [Abstract][Full Text] [Related]
5. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
6. TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers.
Singh A; Sweeney MF; Yu M; Burger A; Greninger P; Benes C; Haber DA; Settleman J
Cell; 2012 Feb; 148(4):639-50. PubMed ID: 22341439
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke mediates epigenetic repression of miR-487b during pulmonary carcinogenesis.
Xi S; Xu H; Shan J; Tao Y; Hong JA; Inchauste S; Zhang M; Kunst TF; Mercedes L; Schrump DS
J Clin Invest; 2013 Mar; 123(3):1241-61. PubMed ID: 23426183
[TBL] [Abstract][Full Text] [Related]
8. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas.
Obrador-Hevia A; Chin SF; González S; Rees J; Vilardell F; Greenson JK; Cordero D; Moreno V; Caldas C; Capellá G
J Pathol; 2010 May; 221(1):57-67. PubMed ID: 20196079
[TBL] [Abstract][Full Text] [Related]
10. Foxm1 mediates cross talk between Kras/mitogen-activated protein kinase and canonical Wnt pathways during development of respiratory epithelium.
Wang IC; Snyder J; Zhang Y; Lander J; Nakafuku Y; Lin J; Chen G; Kalin TV; Whitsett JA; Kalinichenko VV
Mol Cell Biol; 2012 Oct; 32(19):3838-50. PubMed ID: 22826436
[TBL] [Abstract][Full Text] [Related]
11. The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancer.
Kumar MS; Hancock DC; Molina-Arcas M; Steckel M; East P; Diefenbacher M; Armenteros-Monterroso E; Lassailly F; Matthews N; Nye E; Stamp G; Behrens A; Downward J
Cell; 2012 Apr; 149(3):642-55. PubMed ID: 22541434
[TBL] [Abstract][Full Text] [Related]
12. Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas.
McCleland ML; Adler AS; Deming L; Cosino E; Lee L; Blackwood EM; Solon M; Tao J; Li L; Shames D; Jackson E; Forrest WF; Firestein R
Clin Cancer Res; 2013 Feb; 19(4):773-84. PubMed ID: 23224736
[TBL] [Abstract][Full Text] [Related]
13. KRAS and cancer stem cells in APC-mutant colorectal cancer.
Fearon ER; Wicha MS
J Natl Cancer Inst; 2014 Feb; 106(2):djt444. PubMed ID: 24491303
[No Abstract] [Full Text] [Related]
14. Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.
Sunaga N; Kaira K; Imai H; Shimizu K; Nakano T; Shames DS; Girard L; Soh J; Sato M; Iwasaki Y; Ishizuka T; Gazdar AF; Minna JD; Mori M
Oncogene; 2013 Aug; 32(34):4034-42. PubMed ID: 22964644
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA mutation uncouples tumor growth and cyclin D1 regulation from MEK/ERK and mutant KRAS signaling.
Halilovic E; She QB; Ye Q; Pagliarini R; Sellers WR; Solit DB; Rosen N
Cancer Res; 2010 Sep; 70(17):6804-14. PubMed ID: 20699365
[TBL] [Abstract][Full Text] [Related]
16. A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer.
Park J; Cho YH; Shin WJ; Lee SK; Lee J; Kim T; Cha PH; Yang JS; Cho J; Min DS; Han G; Lee HY; Choi KY
Sci Rep; 2019 Jan; 9(1):648. PubMed ID: 30679620
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells.
Mologni L; Brussolo S; Ceccon M; Gambacorti-Passerini C
PLoS One; 2012; 7(12):e51449. PubMed ID: 23227266
[TBL] [Abstract][Full Text] [Related]
18. MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways.
Patel A; Burton DG; Halvorsen K; Balkan W; Reiner T; Perez-Stable C; Cohen A; Munoz A; Giribaldi MG; Singh S; Robbins DJ; Nguyen DM; Rai P
Oncogene; 2015 May; 34(20):2586-96. PubMed ID: 25023700
[TBL] [Abstract][Full Text] [Related]
19. Wnt/β-catenin and MAPK signaling: allies and enemies in different battlefields.
Guardavaccaro D; Clevers H
Sci Signal; 2012 Apr; 5(219):pe15. PubMed ID: 22494969
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of beta-catenin induces pancreas tumor formation.
Heiser PW; Cano DA; Landsman L; Kim GE; Kench JG; Klimstra DS; Taketo MM; Biankin AV; Hebrok M
Gastroenterology; 2008 Oct; 135(4):1288-300. PubMed ID: 18725219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
